AIRLINK 74.01 Decreased By ▼ -0.55 (-0.74%)
BOP 5.01 Decreased By ▼ -0.05 (-0.99%)
CNERGY 4.47 Increased By ▲ 0.01 (0.22%)
DFML 41.55 Increased By ▲ 1.82 (4.58%)
DGKC 87.14 Decreased By ▼ -0.41 (-0.47%)
FCCL 21.79 Decreased By ▼ -0.14 (-0.64%)
FFBL 34.20 Decreased By ▼ -0.39 (-1.13%)
FFL 9.98 Increased By ▲ 0.23 (2.36%)
GGL 10.45 Decreased By ▼ -0.04 (-0.38%)
HBL 113.58 Decreased By ▼ -0.21 (-0.18%)
HUBC 136.00 Decreased By ▼ -0.52 (-0.38%)
HUMNL 11.90 Increased By ▲ 1.00 (9.17%)
KEL 4.85 Increased By ▲ 0.18 (3.85%)
KOSM 4.56 Decreased By ▼ -0.08 (-1.72%)
MLCF 38.30 Decreased By ▼ -0.16 (-0.42%)
OGDC 135.70 Decreased By ▼ -0.44 (-0.32%)
PAEL 26.72 Increased By ▲ 0.11 (0.41%)
PIAA 20.80 Decreased By ▼ -1.69 (-7.51%)
PIBTL 6.75 Increased By ▲ 0.08 (1.2%)
PPL 122.40 Increased By ▲ 0.11 (0.09%)
PRL 26.93 Decreased By ▼ -0.04 (-0.15%)
PTC 14.49 Increased By ▲ 0.58 (4.17%)
SEARL 59.61 Decreased By ▼ -0.26 (-0.43%)
SNGP 70.00 Decreased By ▼ -0.06 (-0.09%)
SSGC 10.34 Decreased By ▼ -0.01 (-0.1%)
TELE 8.59 Increased By ▲ 0.05 (0.59%)
TPLP 11.33 Decreased By ▼ -0.01 (-0.09%)
TRG 65.30 Decreased By ▼ -0.70 (-1.06%)
UNITY 26.16 Decreased By ▼ -0.17 (-0.65%)
WTL 1.34 Decreased By ▼ -0.01 (-0.74%)
BR100 7,860 Increased By 35.9 (0.46%)
BR30 25,386 Decreased By -19.5 (-0.08%)
KSE100 75,259 Increased By 175.2 (0.23%)
KSE30 24,179 Increased By 85.1 (0.35%)
World

EU Commission to end AstraZeneca and J&J vaccine contracts at expiry

  • It added that Brussels would rather focus on COVID-19 vaccines using messenger RNA (mRNA) technology, such as Pfizer's and Moderna's.
Published April 14, 2021

MILAN: The EU Commission has decided not to renew COVID-19 vaccine contracts next year with companies such as Astrazeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on Wednesday citing a source from the Italian Health Ministry.

"The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed at their expiry," the newspaper reported.

It added that Brussels would rather focus on COVID-19 vaccines using messenger RNA (mRNA) technology, such as Pfizer's and Moderna's.

The European Commission is seeking clarification from J&J about the company's "completely unexpected" announcement of delays in COVID-19 vaccine deliveries to the EU, an EU official told Reuters on Tuesday.

Comments

Comments are closed.